SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Satsuma Pharmaceuticals, Inc. STSA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Satsuma Pharmaceuticals, Inc. (STSA) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ACHL, ADXN, AMTI, ASMB, BLCM, CING 等.

STSA 的市值为 $36.47M, 而同行平均市值为 $650.54M. STSA 显著小于其平均同行.

同行与相似公司 — STSA

Achilles Therapeutics plc

$1.48 +0.68% $60.83M

Addex Therapeutics Ltd

$7.00 -2.78% $4.62M

Applied Molecular Transport Inc.

$0.26 -3.13% $11.01M

Assembly Biosciences, Inc.

$29.81 +1.26% $472.87M

Bellicum Pharmaceuticals, Inc.

$0.07 -6.68% $778.33K

$5.20 -2.80% $29.15M

CytomX Therapeutics, Inc.

$4.56 +0.44% $776.34M

Cyclerion Therapeutics, Inc.

$3.03 -5.90% $13.12M

Eliem Therapeutics, Inc.

$5.11 -0.97% $342.68M

$18.20 +1.96% $5.66B

Forte Biosciences, Inc.

$31.28 -3.52% $434.34M

Hillstream BioPharma, Inc.

$0.24 +5.66% $4.17M

其他人也在看

CytomX Therapeutics, Inc.

Assembly Biosciences, Inc.

Forte Biosciences, Inc.

Larimar Therapeutics, Inc.

Eliem Therapeutics, Inc.

Theseus Pharmaceuticals, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言